Ambrisentan Therapy in Patients With Pulmonary Arterial Hypertension Who Discontinued Bosentan or Sitaxsentan Due to Liver Function Test Abnormalities von MCGOON, Michael D, FROST, Adaani E, RUBIN, Lewis, OUDIZ, Ronald J, BADESCH, David B, CALIE, Nazzareno, OLSCHEWSKI, Horst, MCLAUGHLIN, Vallerie V, CERBER, Michael J, DUFTON, Chris, DESPAIN, Darrin J

Volltext